Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

Google's DeepMind spinoff Isomorphic Labs expects clinical trial of drugs it designed using AI to start this year.

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

AI creatives with access to Google’s Veo 2 text-to-video tool say it’s another “leap forward” for video generation Veo 2 ...

The order, signed in October 2023, required companies building powerful AI systems to share their safety test results with the federal government and come up with ways to limit their models’ biases ...

The company fulfilled requests from Israel’s military for more access to AI tools as it sought to compete with Amazon, ...

Google DeepMind AI for Science Scholarships are now available, offering African students the opportunity to pursue ...

Demis Hassabis is the CEO of Google DeepMind. Demis thinks new agent type systems will be able to perform additional tree of knowledge search to achieve ...

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

Google DeepMind Chief Operations Officer Lila Ibrahim discussed the changes that the Trump administration may bring, ...

With "Mind Evolution" LLMs can use search and genetic algorithms to generate and combine different solutions and find the optimal one.

Business Insider's diary takes you behind the scenes on day three of the World Economic Forum in Davos.